Next Article in Journal
Real World Outcomes versus Clinical Trial Results of Durvalumab Maintenance in Veterans with Stage III Non-Small Cell Lung Cancer
Next Article in Special Issue
Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted
Previous Article in Journal
The Central Role of the Ubiquitin–Proteasome System in EBV-Mediated Oncogenesis
Previous Article in Special Issue
The Tumour Suppressor CYLD Is Required for Clathrin-Mediated Endocytosis of EGFR and Cetuximab-Induced Apoptosis in Head and Neck Squamous Cell Carcinoma
 
 
Systematic Review

Article Versions Notes

Cancers 2022, 14(3), 612; https://doi.org/10.3390/cancers14030612
Action Date Notes Link
article xml file uploaded 26 January 2022 10:23 CET Original file -
article xml uploaded. 26 January 2022 10:23 CET Update -
article pdf uploaded. 26 January 2022 10:23 CET Version of Record https://www.mdpi.com/2072-6694/14/3/612/pdf-vor
article supplementary file uploaded. 26 January 2022 10:23 CET - https://www.mdpi.com/2072-6694/14/3/612#supplementary
article html file updated 26 January 2022 10:24 CET Original file -
article xml file uploaded 27 January 2022 06:22 CET Update -
article xml uploaded. 27 January 2022 06:22 CET Update https://www.mdpi.com/2072-6694/14/3/612/xml
article pdf uploaded. 27 January 2022 06:22 CET Updated version of record https://www.mdpi.com/2072-6694/14/3/612/pdf
article html file updated 27 January 2022 06:23 CET Update -
article html file updated 31 July 2022 06:15 CEST Update https://www.mdpi.com/2072-6694/14/3/612/html
Back to TopTop